Pharvaris

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pharvaris and other ETFs, options, and stocks.

About PHVS

Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. 

CEO
Berndt A. E. Modig
CEOBerndt A. E. Modig
Employees
108
Employees108
Headquarters
Leiden, Zuid-Holland
HeadquartersLeiden, Zuid-Holland
Founded
2015
Founded2015
Employees
108
Employees108

PHVS Key Statistics

Market cap
981.42M
Market cap981.42M
Price-Earnings ratio
-5.96
Price-Earnings ratio-5.96
Dividend yield
Dividend yield
Average volume
29.79K
Average volume29.79K
High today
High today
Low today
Low today
Open price
$19.00
Open price$19.00
Volume
0.00
Volume0.00
52 Week high
$25.50
52 Week high$25.50
52 Week low
$11.51
52 Week low$11.51

Analyst ratings

91%

of 11 ratings
Buy
90.9%
Hold
0%
Sell
9.1%

People also own

Based on the portfolios of people who own PHVS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.